Food and Drug Administration (FDA)

SINGAPORE (Feb 21): At the SLINGSHOT 2019 start-up competition that took place during the Singapore FinTech Festival late last year, Breathonix was declared as one of two sector winners for the HealthTech, BioTech and MedTech category. The company beat mo

SINGAPORE (Jan 4): STS Medical, a portfolio company of The Trendlines Group, has received regulatory clearance from the US Food and Drug Administration (FDA) for its composite sinus stent which is designed to reduce the probability of revision surgeries a

SINGAPORE (Dec 7): Gordian Surgical, a medical portfolio company of Trendlines Group, has completed a recent financing round of US$2.25 million ($3.2 million).